GSK Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 6, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
Related Tickers: GSK
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on May 6, 2025, that it has purchased a number of its own ordinary shares. The transactions were carried out by its corporate stockbroker, Citigroup Global Markets Limited.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of share transactions and does not indicate any new or significant risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker executing share purchases
- May 2025 (date) — Reporting period for the transaction
FAQ
What type of transaction is GSK plc reporting?
GSK plc is reporting a transaction in its own shares.
Who is acting as GSK's stockbroker for these transactions?
Citigroup Global Markets Limited is acting as GSK's corporate stockbroker.
What is the reporting period for this Form 6-K?
The reporting period for this Form 6-K is the month of May 2025.
What is the principal executive office address of GSK plc?
The principal executive office address of GSK plc is 79 New Oxford Street, London, WC1A 1DG.
Does GSK plc file annual reports under Form 20-F or Form 40-F?
GSK plc indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 6, 2025 regarding GSK plc (GLAXF).